Hemophilia Treatment Market Size, Major Strategies, Key Companies, Revenue Share Analysis Till 2027
 |
| Hemophilia Treatment Market |
The global hemophilia market is forecasted to witness a steady growth of 6.10% during the forecast period between 2018 to 2023. The market valuation is slated to jump from USD 11,257.21 Mn in 2017 to USD 16,059.17 Mn by the end of the forecast period.
The report
published by Market Research Future (MRFR) identifies that the prevalence of
hemophilia will spring up the demand for hemophilia treatment globally. The
emergence of recombinant products for the treatment of hemophilia has blossomed
the interest and demand for the market. The absence of a precise cure and the
growing setbacks with the treatment of hemophilia has increased the need for
discovering and coming up with new and effective solutions. Gene therapy is
increasingly being explored and considered as a permanent solution for
hemophilia and offers vast opportunities for the growth of the market.
However,
the high cost associated with the treatment and the level of expenses required
for consistent lab testing and imaging tests can go on to hamper the market
growth of hemophilia treatment.
Request
Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5688
Market
Segmentation
The global
hemophilia treatment market segmentation is based in terms of type, end-user,
and treatment.
By type,
the market is categorized into hemophilia A, hemophilia B, and hemophilia C.
The hemophilia A segment holds the largest share of the global market. The
valuation of the segment is expected to reach USD 12.697.99 by the end of the
forecast period, 2023. The calculated growth rate of the market annually has been
projected to be 6.23% during the forecast period.
By
treatment, the market comprises of recombinant coagulation factor concentrates,
plasma-derived coagulation factor concentrates, desmopressin, gene therapy, and
antifibrinolytic agents. The recombinant coagulation factor concentrates is the
largest market share holder with an expected CAGR of 7.01% during the review
period.
By
end-users, the market includes hospitals & clinics, research organization,
and others. Hospitals & clinics lead this segmentation of the market and is
valued at USD 7594.66 Mn in 2017 and is expected to grow the fastest over the
forthcoming years.
Regional
Analysis
The
regional segmentation of the hemophilia treatment market covers the following
regions: North America, Europe, Asia Pacific, Latin America, and the Middle
East and Africa.
The
Americas stand tall as the largest market share holder in the global
geographical segmentation. This is due to the prevalence of the hemophilia
disorder and the presence of a well-established healthcare sector. Growing
expenditure in healthcare and increasing support for research and development
activities are expected to aid the Americas region to maintain its leadership
position. The North American market contributes more to the region than its southern
counterpart.
Europe
holds the second biggest market share due to a parallel growth pattern like the
Americas. Moreover, government support for R&D activities for advanced
medical therapies for hemophilia is another important driver to the market growth
in this region.
Asia
Pacific is expected to grow with the highest CAGR of 8.38% during the review
period. The healthcare sector in this region is advancing at a rapid pace owing
to the high disposable income in the region and expanding advanced medical
facilities. The presence of a vast patient population base and a high
healthcare expenditure is expected to positively impact the Asia Pacific market
growth.
Competitive
Landscape
The global
hemophilia treatment market includes various noteworthy players like Baxter,
F.Hoffmann-La Roche Ltd, Octapharma, Swedish Orphan Biovitrum AB, Pfizer Inc,
CSL Behring, Sanofi, Kedrion, Novo Nordisk A/S, Bayer AG, Grifols International
S.A, and Shire.
Browse
Complete Report Details @ https://www.marketresearchfuture.com/reports/hemophilia-treatment-market-5688
About
Market Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Have
a Look at Related Reports:
Medical
Second Opinion Market - https://www.globenewswire.com/news-release/2021/08/23/2285025/0/en/Medical-Second-Opinion-Market-Size-Worth-USD-9751-58-Million-by-2027-at-15-8-CAGR-Report-by-Market-Research-Future-MRFR.html
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street, 5Th Floor,
New York,
New York 10013
United
States of America
+1 628 258
0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment